Home IFTTT Startups – TechCrunch Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes

Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes

,
 Fractyl Labs, a Lexington, Massachusetts-based startup developing treatments for diabetes, has raised $44 million in Series D financing from a slew of VC firms, including GV, True Ventures, the IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, L.P., and Deerfield Management Company, L.P. Fractyl has been working on… Read More Post by startupsnows.blogspot.com
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes Reviewed by Unknown on 4:09 AM Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.